Latest filing published 01 Sept 2021 for Cryo Cell International INC, €43k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 106 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -10.5%Entry US$7.91 · Close at T+365 US$7.08
- -6.3%Entry US$8.05 · Close at T+365 US$7.54
- +24.1%Entry US$2.78 · Close at T+365 US$3.45
- +17.9%Entry US$2.80 · Close at T+365 US$3.30
- +13.3%Entry US$3.00 · Close at T+365 US$3.40
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
George Gaines: trading record in brief
George Gaines is a declared insider of Cryo Cell International Inc (board member), with filings sourced from SEC (Form 4). The record holds 130 filings, for trades running from 30 July 2012 to 1 September 2021.
On the open market, the record shows 106 purchases worth €626k and 23 sales worth €635k. Sales outweigh purchases by €8,904. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 1 option exercise. In 2021 alone, the filings show no purchases and 12 sales.
A typical purchase (the median) is worth €3,267. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. After 106 purchases with a full 90-day history, the hit rate stands at 42% and the median 90-day move at -4.5%. This is a record of the past, not a forecast.
Most recently, on 1 September 2021, the filings show an open-market sale worth €43k in Cryo Cell International Inc. The last purchase on record was published on 4 September 2018, which is 2,987 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to George Gaines
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,400 shares@ US$11.506.1% of flowCommon StockSEC:0001209191-21-054280:1
- 3,800 shares@ US$11.405.2% of flowCommon StockSEC:0001209191-21-054280:2
- 10 shares@ US$11.710.0% of flowCommon StockSEC:0001209191-21-054280:3
- 278 shares@ US$11.700.4% of flowCommon StockSEC:0001209191-21-054280:4
- 2,041 shares@ US$11.602.9% of flowCommon StockSEC:0001209191-21-054280:5
- 1 shares@ US$11.500.0% of flowCommon StockSEC:0001209191-21-054280:6
- 3,699 shares@ US$11.705.2% of flowCommon StockSEC:0001209191-21-054280:7
- 1,800 shares@ US$11.60100.0% of flowCommon StockSEC:0001209191-21-054280:0
- 450 shares@ US$10.000.5% of flowCommon StockSEC:0001209191-21-019527:0
- 2,971 shares@ US$10.103.5% of flowCommon StockSEC:0001209191-21-019527:1
- 500 shares@ US$10.150.6% of flowCommon StockSEC:0001209191-21-018297:0
- 550 shares@ US$10.000.6% of flowCommon StockSEC:0001209191-21-018297:1
- 2,878 shares@ US$9.605.1% of flowCommon StockSEC:0001209191-20-046824:0
- 120 shares@ US$9.330.2% of flowCommon StockSEC:0001209191-20-046824:1
- 100 shares@ US$9.300.2% of flowCommon StockSEC:0001209191-20-046824:2
- 3,615 shares@ US$9.006.0% of flowCommon StockSEC:0001209191-20-046824:3
- 760 shares@ US$8.801.2% of flowCommon StockSEC:0001209191-20-046824:4
- 4,256 shares@ US$8.506.6% of flowCommon StockSEC:0001209191-20-044482:0
- 8,944 shares@ US$8.5514.0% of flowCommon StockSEC:0001209191-20-044482:1
- 20,000 shares@ US$8.2531.0% of flowCommon stockSEC:0000899243-20-020557:0
- 4,955 shares@ US$8.207.8% of flowCommon stockSEC:0000899243-20-016676:0
- 10,045 shares@ US$8.2515.9% of flowCommon stockSEC:0000899243-20-016676:1
- 5,000 shares@ US$8.308.0% of flowCommon stockSEC:0000899243-20-016676:2
- 2,700 shares@ US$8.003.5% of flowCommon StockSEC:0000899243-18-023732:0Canonical exit: 28 Nov 2018 (T+90)
- 100 shares@ US$7.950.1% of flowCommon StockSEC:0000899243-18-023732:1Canonical exit: 28 Nov 2018 (T+90)
25 of 130 declarations